TACE inhibitors (ULS)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameTACE inhibitors (ULS)
Drug Alias NameADAM 17 inhibitors (InhibOx)TNF-alpha converting enzyme inhibitors (InhibOx)TACE inhibitors (InhibOx)TNF-alpha converting enzyme inhibitors (ULS)ADAM 17 inhibitors (ULS)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDisintegrin and metalloproteinase domain-containing protein 17 inhibitors
TargetsDisintegrin and metalloproteinase domain-containing protein 17
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOxford Drug Design
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOxford Drug DesignUnion Life Sciences Ltd
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A